systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-720Research ArticleСТАТЬИARTICLESИлопрост - ингаляционный аналог простациклина для лечения больных легочной гипертензиейМартынюкТ. В.noemail@neicon.ruЧазоваИ. Е.noemail@neicon.ruИнститут клинической кардиологии им. А.Л.Мясникова ФГУ РКНПК Минздравсоцразвития РФ, МоскваRussian Federation201109022023845763Copyright © Мартынюк Т.В., Чазова И.Е., 20232023Мартынюк Т.В., Чазова И.Е.Мартынюк Т.В., Чазова И.Е.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/720ReferencesGuidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the ECS and ERS, endorsed by the ISHLT. Eur Heart J 2009; 30: 2493-537.Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the ECS and ERS, endorsed by the ISHLT. Eur Heart J 2009; 30: 2493-537.Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31(4): 881-901.Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008; 31(4): 881-901.McLaughlin et al. Survival in primary pulmonary hypertension. The impaсt of epoprostenol therapy. Circulanion 2002; 106: 1477-82.McLaughlin et al. Survival in primary pulmonary hypertension. The impaсt of epoprostenol therapy. Circulanion 2002; 106: 1477-82.Higenbottam T, Wheeldon D, Wells et al. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984; 1: 1046-7.Higenbottam T, Wheeldon D, Wells et al. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet 1984; 1: 1046-7.Barst RJ, Rubin LJ et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.Barst RJ, Rubin LJ et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.Sitbon O, Humbert M et al. Long-term intravenous epoprostenol infusion in privary pulmonari hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-8.Sitbon O, Humbert M et al. Long-term intravenous epoprostenol infusion in privary pulmonari hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-8.Olschewski H, Ghofrani HA et al. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med 2000; 132: 435-43.Olschewski H, Ghofrani HA et al. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med 2000; 132: 435-43.Olschewski H, Walmrath D, Schermuly R et al. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124: 820-4.Olschewski H, Walmrath D, Schermuly R et al. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124: 820-4.Olschewski H, Simonneau G, Galie N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-9.Olschewski H, Simonneau G, Galie N et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-9.Olschewski H, Hoeper MM, Behr J et al. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 2010; 104: 731-40.Olschewski H, Hoeper MM, Behr J et al. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 2010; 104: 731-40.McLaughlin V, Oudiz R, Frost A. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2006; 174: 1257-63.McLaughlin V, Oudiz R, Frost A. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2006; 174: 1257-63.
The authors declare that there are no conflicts of interest present.